AI & ChatGPT searches , social queries for IGFBPS
What is the meaning of IGFBPS. Phrases containing IGFBPS
See meanings and uses of IGFBPS!
What is the meaning of IGFBPS. Phrases containing IGFBPS
See meanings and uses of IGFBPS!IGFBPS
Transport protein for insulin-like growth factor 1
liver to produce more IGF-1. IGF binding proteins (IGFBPs) are proteins of 24 to 45 kDa. All six IGFBPs share 50% homology with each other and have binding
Insulin-like growth factor–binding protein
Insulin-like_growth_factor–binding_protein
Synthetic protein
very low affinity for the insulin-like growth factor-binding proteins (IGFBPs), and has improved metabolic stability. As a result, it is approximately
IGF-1_LR3
Protein found in humans
hormone (GH). Most of IGF1 is bound to one of 6 binding proteins (IGF-BP). IGFBP-1 is regulated by insulin. IGF1 is produced throughout life; the highest
Insulin-like_growth_factor_1
Proteins similar to insulin that stimulate cell proliferation
suggesting that IGFBPs play important roles in addition to their ability to regulate IGFs. IGF-1 and IGFBP-3 are GH dependent, whereas IGFBP-1 is insulin
Insulin-like_growth_factor
Protein-coding gene in the species Homo sapiens
but this ignores IGF-1 binding to other IGFBPs (so the ratio is affected by the concentrations of all six IGFBPs), and the fact that IGF-2, which is three
IGFBP3
the liver. IGF-1 has six binding proteins (IGFBPs), exhibiting different effects on body tissues, where IGFBP-3 is most abundant in human circulation. IGF-1
Development_of_the_human_body
Protein-coding gene in the species Homo sapiens
binding to its receptors. IGFBP7 binds to IGF with low affinity compared to IGFBPs 1-6. It also stimulates cell adhesion. The protein is implicated in some
IGFBP7
Protein
considerably reduced binding to the insulin-like growth factor-binding proteins (IGFBPs) and enhanced potency (about 10-fold in vivo) relative to IGF-1. The amino
Des(1-3)IGF-1
Chemical compound
males. Testosterone enanthate can also lead to an increase in IGF-1 and IGFBP. Testosterone enanthate can also be converted to estradiol (E2) by the aromatase
Testosterone_enanthate
Peptide hormone
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Insulin
Corticosteroid medication
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Dexamethasone
Small neuroactive peptide
family comprises IGF-1, IGF receptors (IGF-1R) and IGF binding proteins (IGFBP). The therapeutic applications of IGF-1 are limited due to its poor central
Cyclic_glycine-proline
Class of enzymes
metalloproteinase which cleaves insulin-like growth factor binding proteins (IGFBPs). PAPPA's proteolytic function is activated upon collagen binding. It is
Pappalysin-1
First stage of pregnancy
collagen Heparan sulfate Proteoglycan Integrins – Others: Mucins Prolactin IGFBP-1 Glycodelin Endometrial protein 15 Albumin Beta-Lipoprotein Relaxin Fibroblast
Implantation_(embryology)
Protein-coding gene in the species Homo sapiens
Insulin-like growth factor-binding protein 6 (IGFBP-6) is a protein that in humans is encoded by the IGFBP6 gene. GRCm38: Ensembl release 89: ENSMUSG00000023046
IGFBP6
Peptide hormone produced by cows' pituitary glands
PMID 15687675. Rinaldi, S; Peeters, PH; Berrino, F; et al. (2006). "IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation
Bovine_somatotropin
Protein-coding gene in the species Homo sapiens
insulin-like growth factor binding proteins (IGFBPs). Isolation of IGFBP-2, an altered form of IGFBP-3 and a new IGFBP species". Growth Regul. 1 (3): 125–30
IGFBP2
Medication and naturally occurring steroid hormone
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Testosterone_(medication)
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Ponazuril
Enzyme
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Tyrosine_kinase
Primary male sex hormone
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Testosterone
Medical condition
clinical evaluation may include laboratory analysis of basal GH, IGF-1 and IGFBP levels, GH stimulation testing, and/or GH trial therapy. People with LS
Laron_syndrome
Protein-coding gene in the species Homo sapiens
factor-binding protein 3 receptor or IGFBP-3R is a protein that in humans is encoded by the TMEM219 gene. IGFBP-3R acts as a cell death receptor for IGFBP3
TMEM219
Pharmaceutical drug
of mecasermin (rhIGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), and insulin-like growth factor binding protein acid labile subunit (IGFALS)
Mecasermin
Medical usage of the prasterone compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Prasterone
Tricyclic antidepressant
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Amitriptyline
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
GDNF_family_of_ligands
Combination drug
Mecasermin rinfabate (INN, USAN) (brand name Iplex), also known as rhIGF-1/rhIGFBP-3, is a drug consisting of recombinant human insulin-like growth factor
Mecasermin_rinfabate
hormone binding protein (GHBP), insulin-like growth factor-binding proteins (IGFBPs), and copper binding protein (CBP), suppresses growth hormone (GH)-mediated
Pharmacokinetics_of_estradiol
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Cabozantinib
Chemical compound, used as a medication to treat lung cancer
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Osimertinib
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Imatinib
Protein-coding gene in the species Homo sapiens
of the Insulin-like growth factor-binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a type-I thyroglobulin domain. The protein
IGFBP1
Medication which blocks growth of blood vessels
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Anti-VEGF
Group of signal transduction pathways involved in embryonic development
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Wnt_signaling_pathway
Experimental drug for neurodegenerative disorders
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Cerebrolysin
Asashima, Makoto; Komuro, Issei (February 13, 2014). "Correction: Corrigendum: IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis"
Japanese scientific misconduct allegations
Japanese_scientific_misconduct_allegations
Protein that stimulates red blood cell production
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Erythropoietin
Cancer treatment medicine
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Sorafenib
Mammalian protein found in Homo sapiens
receptor-related protein 1, LDL receptor related protein 1, KPA, IGFBP3R1, IGFBP-3R External IDs OMIM: 107770; MGI: 96828; HomoloGene: 1744; GeneCards: LRP1;
LRP1
Mammalian protein found in Homo sapiens
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
FGF5
Protein found in humans
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Brain-derived neurotrophic factor
Brain-derived_neurotrophic_factor
Medication
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Trastuzumab
Lake in Aragatsotn Region, Armenia
Cross Cattle based on SNP in Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) gene sequences". Biodiversitas Journal of Biological Diversity. 18 (2):
Lake_Lessing
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Linsitinib
Medication
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Bevacizumab
Transmembrane receptors involved in cellular adhesion and signalling
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Integrin
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Dusigitumab
Monoclonal antibody
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Duligotuzumab
Mammalian protein found in humans
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
HER2
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Nintedanib
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Pralsetinib
Medication used for cancer
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Gefitinib
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Encorafenib
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Tucatinib
Protein or other substance that stimulates cellular proliferation
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Growth_factor
Mammalian protein found in Homo sapiens
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Hepatocyte_growth_factor
Pharmaceutical drug
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Cetuximab
Protein-coding gene in the species Homo sapiens
of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein
IGFBP4
Medication
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Filgrastim
Gene involved in the most common form of dwarfism
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Fibroblast growth factor receptor 3
Fibroblast_growth_factor_receptor_3
Protein-coding gene in humans
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
PDGFRB
Cell receptor protein found in humans
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Insulin-like growth factor 1 receptor
Insulin-like_growth_factor_1_receptor
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
K252a
Class of drugs used to treat malignant tumors
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Antineoplastic
Human protein-coding gene
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Low-affinity nerve growth factor receptor
Low-affinity_nerve_growth_factor_receptor
Protein-coding gene in the species Homo sapiens
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Midkine
Protein-coding gene in the species Homo sapiens
insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human". J. Biol. Chem. 266 (16):
IGFBP5
Protein family
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Receptor activity-modifying protein
Receptor_activity-modifying_protein
Neural, cognitive, and behavioral effects of physical exercise
ISBN 978-0-07-148127-4. Gatti R, De Palo EF, Antonelli G, Spinella P (July 2012). "IGF-I/IGFBP system: metabolism outline and physical exercise". J. Endocrinol. Invest
Neurobiological effects of physical exercise
Neurobiological_effects_of_physical_exercise
Monoclonal antibody
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Flanvotumab
Selective estrogen receptor modulator
also been found to increase insulin-like growth factor binding protein 3 (IGFBP-3) levels in pre- and postmenopausal women. Due to activation of estrogen
Raloxifene
Protein-coding gene in the species Homo sapiens
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
RAMP2
Protein-coding gene in the species Homo sapiens
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Angiopoietin_1
Pharmaceutical drug
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Pertuzumab
Protein involved in cell adhesion, cell growth, cell migration and differentiation
"Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma". The
Fibronectin
Protein found in humans
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Ephrin_B1
Drug typically used in cancer treatment
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Tyrosine_kinase_inhibitor
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Dihexa
Targeted cancer drug
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Vemurafenib
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Foretinib
Proteoglycan; lubricant; gene
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Proteoglycan_4
Mammalian protein found in humans
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Nerve_growth_factor
Protein and coding gene in humans
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Tropomyosin_receptor_kinase_B
Monoclonal antibody
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Pegfilgrastim
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Axitinib
Medication
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Amivantamab/hyaluronidase
Common type of liver cancer
loss of autocrine/paracrine IGFBP-3 loops may lead to HCC tumor growth and suggest that modulating production of the IGFs, IGFBP-3, and IGF-IR may represent
Hepatocellular_carcinoma
Class of enzymes
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Receptor_tyrosine_kinase
Protein found in humans
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Fibroblast_growth_factor_23
Family of biomolecules
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Neurotrophic_factors
Protein-coding gene in the species Homo sapiens
DJ, Mohan S (April 2002). "Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2)". J. Biol. Chem
FHL2
Protein-coding gene in humans
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
MST1R
Protein
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
TGF_alpha
Mammalian protein found in Homo sapiens
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Renalase
Chemical compound
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Olmutinib
Transmembrane protein
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Epidermal growth factor receptor
Epidermal_growth_factor_receptor
Chemical compound
growth factor 1 (IGF-1), and insulin-like growth factor-binding protein 3 (IGFBP-3) in humans, without affecting plasma levels of prolactin, cortisol, insulin
Anamorelin
Medication
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
Trastuzumab_deruxtecan
Mammalian protein and protein-coding gene
Dusigitumab Xentuzumab (against IGF-1 and IGF-2) Others Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7) Cleavage products/derivatives with unknown target:
KIT_(gene)
IGFBPS
IGFBPS
IGFBPS
IGFBPS
IGFBPS
IGFBPS
Acronyms & AI meanings
Royal Incorporation of Architects Scotland
longitudinalchromatic aberration
Department of Technology Management
Royal Shakespear Company
Afrika Service Agentur
Toastmaster Of The Year
Circaclian Hyper Amplitude Tension
Digital Ranging Generator
Certified Digital Photo Processor
IGFBPS
IGFBPS
IGFBPS
IGFBPS
IGFBPS